http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
GE Announces $4 Billion of Actions to Further Solidify Financial Position
-
GE Healthcare Expands AI, Digital and Imaging Solutions at #RSNA2020, Helping Shape Future of Healthcare in the COVID Era
-
GE Healthcare Announces First X-ray AI to Help Assess Endotracheal Tube Placement for COVID-19 Patients
-
GE Healthcare Pioneers Photon Counting CT with Prismatic Sensors Acquisition
-
The GE90 Engine Celebrates 25 Years of Service
-
GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the World
-
Tampa General Hospital and GE Healthcare's CareComm Saves $40 Million, Cuts 20,000 Excess Days and Reduces Length of Stay
-
St. Luke’s University Health Network Selects GE Healthcare for $11 Million Ultrasound Purchase to Create System-wide Efficiencies
-
GE Healthcare Introduces Serena Bright, Industry’s First Contrast-Enhanced Guided Biopsy Solution
-
AirAsia and GE Aviation Implement Group-Wide Network Operations Software
-
Uber Elevate and GE Aviation Team to Enhance Safety for Next-Generation Ridesharing
-
GE Healthcare Introduces New Edge Technology Designed to Give Clinicians Rapid Access to Critical Data
-
General Electric (GE) Receives FDA Clearance for Vivid Ultra Edition
-
GE Healthcare Receives FDA Clearance for Vivid Ultra Edition, AI-Powered Cardiovascular Ultrasound System Designed to Shorten Diagnostic Exam Time and Improve Measurement Consistency
-
GE Healthcare Unveils Voluson SWIFT, AI-Enhanced Women’s Health Ultrasound with Industry-First Auto Recognition Tools to Help Improve Efficiency
-
GE Aviation (GE) Announces GE9X Engine Achieves FAA Certification
-
GE9X Engine Achieves FAA Certification
-
GE Healthcare's (GE) Clariscan Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle
-
GE Healthcare’s Clariscan™ (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle
-
GE Healthcare’s Clariscan™ (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle
-
Acerus Announces Addition of US Commercial Leader
-
GE Board of Directors Authorizes Regular Quarterly Dividend
-
Cathay Pacific Group and GE Aviation Expand Digital Partnership
-
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)
-
AiRXOS Launches Public Safety UAS Solution: One Platform to Enable Fast, Safe Drone Operations With Full Situational Awareness; 200 U.S. Public Safety Agencies Pilot Solution
-
AiRXOS Launches New Unmanned Aircraft Systems Solution for Energy Industry
-
General Electric (GE) Names Deloitte as Independent Auditor for 2021
-
GE Names Deloitte as Independent Auditor for 2021
-
GE Board of Directors Authorizes Regular Quarterly Dividend
-
Shorter Scans and Better Image Quality: Deep Learning-Based MR Image Reconstruction Tech From GE Healthcare Now FDA Cleared
-
GE Healthcare Deploys Remote Patient Data Monitoring Technology to Help Clinicians Support Most Critical COVID-19 Patients across the Health System
-
GE to Hold Virtual 2020 Annual Meeting of Shareholders
-
GE Announces Further Actions to Solidify Financial Position
-
General Electric (GE) withdraws guidance for 2020
-
GE Provides Updates on Guidance and First Quarter
-
GE Announces Completion of BioPharma Sale to Danaher, Receives $20 Billion Net Cash Proceeds
-
Ford (F) Works With 3M (MMM), GE (GE), UAW to Speed Production of Respirators for Healthcare Workers, Ventilators for Coronavirus Patients
-
Ford Works With 3M, GE, UAW to Speed Production of Respirators for Healthcare Workers, Ventilators for Coronavirus Patients
-
GE (GE) Announces Update on the Challenge of COVID-19, GE Aviation to Reduce Approximately 10% of its Total U.S. Workforce
-
GE: An Update on the Challenge of COVID-19
-
GE and Danaher Satisfy All Required Regulatory Clearances for BioPharma Transaction; Expect to Close on March 31, 2020
-
GE Nominates Ashton Carter to the Board of Directors
-
Trump blasts proposed U.S. restrictions on sale of jet parts to China
-
GE Board of Directors Authorizes Regular Quarterly Dividend
-
AiRXOS Supercharges Ecosystem Partners to Accelerate Advanced Unmanned Operations – Empowering Customers with End-to-End Unmanned Aircraft System Solution
-
Syniverse and GE Aviation’s AiRXOS Build Communications Network to Secure Drone Flight Operations Communication and Connectivity
-
Boeing's ousted CEO departs with $62 million, even without severance pay
-
New Research Indicates AI May Be Catalyst to Making Healthcare More Human
-
Aerion Supersonic selects GE Aviation as its Electrical Power System provider for the AS2 business jet
-
Apollo (APO) and Athene (ATH) Close Acquisition of GE Capital’s (GE) PK AirFinance Debt Business

